Avrentimsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-02-15
Share capital
50,000.00 PLN
Registered address
Warszawa, Poland

Financials

Filing timeliness

No financial statement for 2019 – the filing deadline has passed. 1 of 1 financial statements was filed late (for 2018, 22 days late).

  • 2019not filed
  • 201806/08/2019
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2018.

Results vs industry

Revenue
This companyUSD 4.25mMedianUSD 1.07mAverageUSD 22.38m
Net profit
This companyUSD -29.51kMedianUSD 37.33kAverageUSD 879.18k
Operating costs
This companyUSD 3.88mMedianUSD 926.31kAverageUSD 21.06m
Assets
This companyUSD 5.88mMedianUSD 609.81kAverageUSD 11.84m

Authorized Representatives

Maciej Dulczewski – President of the Management Board

Manner of representation

The following is authorized to make declarations of will and sign documents on behalf of the company: in the case of a one-person management board, a member of the management board acting independently; in the case of a multi-member management board, two members of the management board acting jointly, or a member of the management board acting jointly with a commercial proxy.

Ownership

OwnerSharesShare valueStake
Maciej Dulczewskiage 60
99$13,371.1599%
Others
1$135.061%

Beneficial owners

No beneficial owners recorded for the company Avrentim.

Debt

14 closed proceedings recorded in KRZ history.

Registration dateProceeding typeStatus
Jun 7, 2025
Discontinued enforcement proceedings
Closed
Jun 28, 2024
Discontinued enforcement proceedings
Closed
Jan 23, 2024
Discontinued enforcement proceedings
Closed
Dec 27, 2023
Discontinued enforcement proceedings
Closed
Oct 23, 2023
Discontinued enforcement proceedings
Closed

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$55,583

Competitors

Name
Centrala Farmaceutyczna CefarmS.A.
ITPS.A.
Medmess Kropaczewskisp. k.
IMC Impomed CentrumS.A.
Hair Partnerssp. z o.o.
Gtm-Mobil M-T T.Walisiewiczsp. k.
Reynolds Medicalsp. z o.o.
Petronafsp. z o.o.
CryoprofilS.A.
Novisc Pharmasp. z o.o.

Change history

DateEvent
2021-03-08Address change
2011-07-06Address change
2009-10-15Address change
2006-11-02Name change
2005-03-23Address change

FAQ

Last updated: 2026-03-30